LOS ANGELES (AP) _ Puma Biotechnology Inc. (PBYI) on Thursday reported a loss of $400,000 in its third quarter.

On a per-share basis, the Los Angeles-based company said it had a loss of 1 cent.

The biopharmaceutical company posted revenue of $57.1 million in the period.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PBYI at https://www.zacks.com/ap/PBYI

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News